Introduction
Onset of maternal blood flow into the intervillous space of the human placenta at the end of the first trimester of pregnancy enables direct physical interaction between maternal circulating blood cells and the placental syncytiotrophoblast (Huppertz et al. 2012; Jauniaux et al. 2000) . This physical interaction between circulating maternal cells and the syncytiotrophoblast, which completely covers placental villi toward the intervillous space and thereby contributes to the placental barrier, could be regulated by cytokines, chemokines and adherence molecules. Among these, the chemokine fractalkine (CX3CL1) recently attracted increasing attention due to its dual nature, existing both as membrane-bound and soluble forms. While the membranebound form mediates flow-resistant adhesion of leukocytes to endothelial and epithelial cells via its corresponding G protein-coupled, 7-transmembrane receptor CX3CR1, the soluble form arises from metalloprotease-dependent Abstract The chemokine fractalkine (CX3CL1) recently attracted increasing attention in the field of placenta research due to its dual nature, acting both as membranebound and soluble forms. While the membrane-bound form mediates flow-resistant adhesion of leukocytes to endothelial and epithelial cells via its corresponding receptor CX3CR1, the soluble form arises from metalloproteasedependent shedding and bears chemoattractive activity for monocytes, natural killer cells and T cells. In human placenta, fractalkine is expressed at the apical microvillous plasma membrane of the syncytiotrophoblast, which may enable close physical contact with circulating maternal leukocytes. Based on these observations, we tested the hypothesis that fractalkine mediates adhesion of monocytes to the villous trophoblast. Forskolin-induced differentiation and syncytialization of the trophoblast cell line BeWo was accompanied with a substantial upregulation in fractalkine expression and led to increased adhesion of the monocyte cell line THP-1, which preferentially bound to shedding and bears chemoattractive activity for monocytes, natural killer cells and T cells (Imai et al. 1997 ). Thus, fractalkine mediates different steps of leukocyte recruitment, depending on whether it is cleaved or not. Moreover, the fractalkine/CX3CR1 system is suggested to facilitate transendothelial or transepithelial migration (or transmigration) of leukocytes (Schwarz et al. 2010) . From a pathophysiologic point of view, the fractalkine/CX3CR1 system is involved in critical events including fibrogenesis, neuropathic pain sensation, the pathogenesis of certain cancers and neurodegenerative diseases (D'Haese et al. 2012) .
The knowledge regarding a role of the fractalkine/ CX3CR1 system in human placental development and physiology is restricted to a very small number of studies. Initial expression analyses and migration assays with trophoblast cell lines suggest a role of fractalkine in establishing first contact between the trophoblast and the uterine wall, and to promote trophoblast migration through the maternal decidua (Cammas et al. 2005; Hannan et al. 2006; Hannan and Salamonsen 2008) . Recently, upregulation of placental fractalkine was suggested to contribute increased fetal microvessel density in placentas from pregnancies complicated by diabetes mellitus (Szukiewicz et al. 2013) . Another study demonstrated increased release of soluble fractalkine into perfusion fluids of perfused placental lobules in response to lipopolysaccharide (LPS) and hypoxia (Szukiewicz et al. 2014b) , indicating upregulation of fractalkine in the placental endothelium under pro-inflammatory conditions. Moreover, increased fractalkine expression has recently been described for human amniotic epithelial cells from pregnancies complicated by chorioamnionitis (Szukiewicz et al. 2014a) .
We have recently shown that placental fractalkine is expressed at the apical microvillous plasma membrane of the syncytiotrophoblast, from where it is released into the maternal circulation by constitutive metalloproteasedependent shedding (Siwetz et al. 2014 ). Inhibition of metalloprotease activity not only impairs the release of soluble fractalkine, but also leads to accumulation of the membrane-bound form. While increased expression and release of placental fractalkine was suggested to contribute to low-grade systemic inflammatory responses in third trimester of normal pregnancy, aberrant placental metalloprotease activity may affect the abundance of the membrane-bound form of fractalkine, giving rise to abnormal interaction of the syncytiotrophoblast with maternal leukocytes. However, a putative role of the fractalkine/CX3CR1 system in the interaction of maternal leukocytes and the syncytiotrophoblast has not been considered so far. Thus, the hypothesis was tested whether or not placental fractalkine can mediate adhesion of monocytes to the villous trophoblast.
Materials and methods

Culture of BeWo cells
BeWo cells were purchased from the European Collection of Cell Cultures (ECACC) and cultured in DMEM/ F12 (1:1, Gibco), supplemented with 10 % FCS (v/v), streptomycin (100 mg/ml), penicillin (100 IU/ml), and l-glutamine (2 mM), at 37 °C in a humidified atmosphere containing 5 % CO 2 in air. Cells between passage 10 and 20 were used for in vitro experiments. BeWo cell differentiation was induced with Forskolin (Sigma), which was supplemented to the culture medium at a final concentration of 20 µM as previously described (Gauster et al. 2010 (Gauster et al. , 2011a .
Culture of THP-1 cells THP-1 cell line was obtained from ECACC and was cultured in RPMI 1640 supplemented with 10 % FCS (v/v), 100 mg/ml streptomycin and 100 IU/ml penicillin (Gibco, Life Technologies).
Isolation and culture of primary term trophoblasts Primary trophoblasts were isolated from chorionic villi of three term placentas with informed consent from the women and approval by the Ethical Committee of the Medical University of Graz. Isolation was performed by enzymatic digestion and Percoll density-gradient centrifugation as described previously (Cervar et al. 1999) . Trophoblasts were cultured in DMEM (Gibco, Life Technologies) with 10 % FCS (v/v), 100 mg/ml streptomycin and 100 IU/ml penicillin (Gibco, Life Technologies). A representative proportion of primary trophoblasts was scrutinized for purity by immunocytochemistry, and viability/differentiation was monitored by measurements of secreted human chorionic gonadotropin (hCG) levels as previously described (Blaschitz et al. 2000; Cervar et al. 1999; Gauster et al. 2011a, b) .
Immunocytochemistry
BeWo cells (8 × 10 4 per well) were seeded in chamber slides (Nunc; Roskilde, Denmark). Next day, BeWo cells were incubated in culture medium supplemented with either Forskolin (20 µM) or vehicle control DMSO (0.2 %) for 48 h. After incubation, cells were washed with PBS, dried and fixed for 10 min in acetone. Chamber slides were rehydrated in PBS, and background blocking was performed with Ultra Vision Protein Block supplemented with 10 % human AB serum for 10 min. Mouse monoclonal anti-human CX3CL1/ fractalkine antibody (R&D Systems, clone 81513, 2 µg/ml working concentration) and mouse monoclonal anti-βhCG (biologo, clone H-298-12, diluted 1:10) were diluted in antibody diluent (DAKO) and incubated on slides for 30 min at RT. After PBS washing steps, slides were incubated with Primary Antibody Enhancer (10 min). After another washing step, detection was achieved by incubation with UltraVision HRP-labeled polymer (15 min) and 3-amino-9-ethylcarbazole (AEC, Dako, Denmark), according to the manufacturer's instructions. For immunocytochemistry of THP-1 cells, cytospins were prepared by spinning 1 × 10 5 THP-1 cells for 5 min at 300×g onto glass slides (Menzel, Braunschweig, Germany). Cytospins were air-dried and fixed for 10 min in acetone. Staining was performed with polyclonal anti-CX3CR1 antibody (C8354, Sigma-Aldrich, 2 µg/ml working concentration) as described above for BeWo cells. For negative controls, slides were incubated with mouse IgG1 (DAK-GO1, DAKO) or rabbit IgG (negative control for rabbit IgG Ab-1, thermo scientific) and revealed no staining. Nuclei were stained with hemalaun, and slides were mounted with Kaiser's glycerol gelatine.
RT-PCR
For RT-PCR, a commercially available RT-PCR Kit (OneStep RT-PCR Kit, Qiagen, Hilden, Germany) was used as previously described (Gauster et al. 2007) . In brief, 100 ng total RNA of each sample was mixed with kit components in a total volume of 20 µl. One step RT-PCR was performed including reverse-transcription at 50 °C for 30 min and a PCR activation step at 95 °C for 15 min. Subsequent threestep cycling was performed with denaturation at 94 °C for 30 s, annealing at 60 °C for 30 s and extension at 72 °C for 1 min using 28 cycles for all used primers. Primers targeting human fractalkine (GGCTCCGATATCTCTGTCGT and CTGTGCTGTCTCGTCTCCAA) and CX3CR1 (TCATC ACCGTCATCAGCATT and GGCTTTCTTGTGGTTCT TGC) were purchased from Microsynth AG (Wolfurt, Austria). Primers for human chorionic gonadotropin betasubunit (βhCG, AGGTCACTTCACCGTGGTCT and GC ACAGATGGTGGTGTTGAC) and ribosomal protein L30 (RPL30: GAAAGTACGTGCTCGGGTACAAACAGACTC and ATCGGAATCACCTGGGTCAATGATAGCCAG) were obtained from Ingenetix (Vienna, Austria). PCR products were separated on 1.5 % (w/v) agarose gels (SeaKem LE Agarose, Cambrex) and images acquired with FluorChem Q System (Alpha Innotech, Cell Bioscienes, Santa Clara, CA, USA).
THP-1 adhesion assay
For THP-1 adhesion experiments, BeWo cells (2 × 10 5 cells/well) and primary term trophoblasts (2 × 10 6 cells/well) were seeded in 12-well culture dishes and 2 ml/well culture medium. One day after seeding, BeWo cells were incubated with culture medium supplemented with either Forskolin (20 µM) or solvent control DMSO (0.2 %) for another 48 h. Primary term trophoblasts were cultured without treatment for 72 h. Thereafter, culture media were replaced by 1 ml RPMI medium containing green fluorescence (CellTracker GreenCMFDA, Life Technologies) labeled THP-1 cells (4 × 10 5 cells/well), and cells were co-cultured at 37 °C for 90 min. Co-culture was followed by three PBS washing steps and subsequent fixation with 4 % formalin (1 ml/well) for 30 min at RT. Acquisition of co-culture images was performed in PBS (2 ml/ well). For CX3CR1-blocking experiments, green fluorescence THP-1 cells (1 × 10 6 /ml) were pre-incubated with recombinant human full length fractalkine (rhCX3CL1/ Fractalkine, R&D Systems, 5 and 10 ng/ml) prior to co-culture at 37 °C for 1 h. After pre-incubation with rhCX3CL1, THP-1 cells were washed and cell number adjusted to 4 × 10 5 cells/well in RPMI. Aliquots of THP-1 cells were pre-incubated in parallel without rhCX3CL1 and served as control. THP-1 adhesion assays were performed as described above. THP-1 adhesion was assessed by acquisition of trophoblast monolayer areas and bound THP-1 cells in phase-contrast and green fluorescence channel, respectively, in a Cell-IQ system (chipman technologies, Tampere, Finland). Pixel areas of bound THP-1 cells were related to pixel areas of trophoblast monolayers in 16 images per well using the Cell-IQ analyzer software.
Assessment of BeWo syncytialization
BeWo cells were seeded in chamber slides (8 × 10 4 per well) and treated with or without Forskolin as described for THP-1 adhesion assay. After co-culture, cells were washed trice in PBS, air-dried and fixed in acetone for 7 min. Fixed co-cultures were subjected to immunofluorescence using a monoclonal anti-α-fodrin antibody (clone AA6, BioTrend, 1:100) to visualize cell borders as previously described (Gauster et al. 2010) . Ten cell layer areas per chamber were systematically randomly selected and microphotographed using a microscope (Leica DM6000B), equipped with a motorized stage, a digital camera (Olympus DP72) and the newCAST stereology software (Visiopharm). BeWo nuclei in syncytia were counted and related to the total number of BeWo nuclei in the selected cell layer areas. In the same images, green fluorescence labeled THP-1 cells were counted and related to the total number of BeWo nuclei. Moreover, THP-1 cells bound to BeWo syncytia were related to those bound to mononucleated BeWo cells.
CX3CR1 silencing in THP-1 cells THP-1 cells (1 × 10 6 ) were seeded in 0.85 ml RPMI without supplements per well in 6-well dishes and starved for 2 h. siRNA-targeting CX3CR1 (5′ GAA AGC CAA AGC CAU UAA A dTdT 3′, Microsynth AG) and a pool of nontargeting control siRNA (ON-TARGETplus control pool, Dharmacon, Thermo Scientific) was used for siRNA-lipid complex preparation by mixing transfection reagent (lipofectamine RNAiMAX, Life Technologies) and siRNA (10 µM) in a ratio of 3:1 (v/v) according to the manufacturer's protocol. After starving, 0.15 ml siRNA-lipid complexes were added to each well and cells incubated for another 4 h. Thereafter, 1 ml RPMI including supplements and 20 % FCS was added to each well to achieve a final FCS concentration of 10 %. Transfected THP-1 cells incubated for 24 h until they were subjected to green fluorescence labeling and adhesion assays described above.
Quantitative real-time PCR (qPCR) analysis of CX3CR1 expression
Total RNA from THP-1 cells was isolated with the Tri Reagent (Molecular Research Center, Cincinnati, OH, USA) and reversely transcribed to cDNA, using high-capacity cDNA reverse-transcription kit (Applied Biosystems; Foster City, CA, USA) according to the manufacturer's instructions. cDNA was subsequently subjected to quantitative real-time PCR using TaqMan Gene Expression Assays for CX3CR1 (Hs00365842_m1) and ribosomal protein L30 (RPL30, Hs00265497_m1) and the TaqMan Universal PCR Mastermix (Applied Biosystems). Components were mixed according to the manufacturer's instructions and amplified in 20μl total volume/well (96-well plates, Roche, Mannheim, Germany) using a Bio-Rad CFX96 Real-Time PCR System. Ct values were automatically generated by the CFX Manager 2.0 Software (Bio-Rad) and relative quantification of gene expression was calculated by standard ΔΔCt method using the expression of RPL30 as reference.
Western blotting THP-1 cells treated with either CX3CR1 siRNA or nontargeting control siRNA were collected, washed in PBS and lysed in RIPA buffer (Sigma-Aldrich) including Protease Inhibitor Cocktail (Roche Diagnostics, Mannheim, Germany) 24 h after transfection. Protein concentration was determined according to Lowry et al., and 40 µg total protein was applied and separated on precast 10 % Bis-Tris gels (NuPAGE, Novex; Invitrogen). After electrophoresis, protein was blotted by semidry blotting on 0.2-µm nitrocellulose membranes (Trans-Blot, Bio-Rad Laboratories) and blotting efficiency was determined by staining membranes with Ponceau S solution (Sigma-Aldrich). Immunodetection was conducted with a chemiluminescent immunodetection kit (Western Breeze; Invitrogen) according to the manufacturer's instructions. Polyclonal anti-human CX3CR1 antibody (SP7048P, Acris) was diluted in blocking solution 1:500 (2 µg/ml working concentration) and applied to the membrane overnight at 4 °C. For normalization, membranes were incubated with monoclonal antibeta-actin antibody (1:20.000; clone AC-15, Abcam, Cambridge, UK). Images were acquired with FluorChem Q System (Alpha Innotech, Cell Bioscienes, Santa Clara, CA, USA), and band densities were analyzed with Alpha View SA software 3.4.0. Cell lysates were analyzed in duplicate from four independent experiments. Results are presented as a ratio of relative CX3CR1 and beta-actin band densities, with non-targeting control siRNA-treated cells set to one.
Statistical analysis
Data were analyzed using SigmaPlot 12.5 and are presented as mean ± SEM. Data were subjected to normality test (Shapiro-Wilk test) and equal variance test. In case of normally distributed data, differences between groups were tested using two-tailed t test. Otherwise, Mann-Whitney rank sum test was applied. For multiple comparison procedure, one-way repeated measures analysis of variance was followed by Holm-Sidak method to isolate groups that differ from the others. A p value of <0.05 was considered statistically significant.
Results
Expression of the fractalkine/CX3CR1 system in trophoblast and monocyte cell lines
Immunocytochemistry of the trophoblast cell line BeWo, a model for the villous trophoblast population, offering good syncytialization and secretion of pregnancy-specific hormones in vitro (Wolfe 2006) , showed virtually no fractalkine expression under basal culture condition (Fig. 1a) . However, in the presence of Forskolin, a reagent known to induce trophoblast differentiation (Wice et al. 1990 ), immunocytochemistry showed fractalkine staining in a considerable proportion of BeWo cells (Fig. 1b) . Differentiation of BeWo cells was confirmed by staining for the beta-subunit of human chorionic gonadotropin (βhCG), which was only sporadically detected under basal culture condition (Fig. 1c) and substantially increased upon Forskolin stimulation (Fig. 1d) . Immunocytochemistry of the monocyte cell line THP-1 revealed a heterogeneous pattern of CX3CR1 expression, with intense staining of a subset of cells and moderate expression in the remaining population (Fig. 1e) . RT-PCR analysis confirmed immunocytochemistry data (Fig. 1f) . Furthermore, no CX3CR1 expression was shown in BeWo cells regardless of stimulation by Forskolin.
Trophoblast syncytialization is accompanied by increased monocyte adhesion
Beside biochemical differentiation of villous trophoblasts resulting in increasing hCG synthesis, morphological differentiation from the mononucleated to the syncytial state can be detected by remodeling of the membrane-associated spectrin-like alpha-fodrin (Gauster et al. 2010 ). Accordingly, BeWo cells under basal culture conditions showed distinct fodrin staining and appeared in a mononucleated state (Fig. 2a) . However, when BeWo cells were undergoing differentiation induced by Forskolin, cell borders and the associated fodrin network vanished in areas of syncytialization (Fig. 2b) , and 33.6 % (±2.72) of nuclei were present in syncytia after 48 h (Fig. 2c) .
Differentiation and syncytialization of BeWo cells led to 3.5-fold increased binding of THP-1 monocytes. While the ratio of adhered monocytes to BeWo nuclei was only 0.10 (±0.01) under basal culture conditions, monocyte adhesion increased to a ratio of 0.36 (±0.04) when BeWo cells underwent Forskolin-induced differentiation before (Fig. 2d) . Assessment of the proportion of monocytes bound to syncytia and those bound to mononucleated BeWo showed preferential adhesion of monocytes (63.6 ± 3.81 %) to syncytia in Forskolin-stimulated BeWo cells (Fig. 2e) . However, when BeWo cells were not stimulated before co-culture with THP-1 monocytes, the majority of monocytes (88.6 ± 2.13 %) adhered to mononucleated cells (Fig. 2e) .
Monocyte adhesion to differentiated trophoblasts is mediated by fractalkine Differentiation and syncytialization of villous trophoblasts gives rise to reduced proliferation and morphological changes (Baczyk et al. 2009; Ramos et al. 2008) . To ensure that obtained adhesion results were not due to a bias in evaluation of adhesion assays and different numbers of trophoblast nuclei in differentiated and non-differentiated cells, a second strategy for analyzing adhesion was performed. This strategy was based on automatic measurement of trophoblast areas in relation to areas of adhered monocytes. For this purpose, phase-contrast images (for trophoblast cell layers) and corresponding green fluorescence channel images (for adhered, green fluorescent labeled THP-1 cells) were taken (Fig. 3a) . Automatic measurement of adhered THP-1 monocytes and trophoblast areas with subsequent relation to each other confirmed initial adhesion assays. If BeWo cells were stimulated with Forskolin for 48 h prior to co-culture, adhesion of THP-1 monocytes increased 4.9-fold (±0.65), compared with control (Fig. 3b) .
In order to test whether or not THP-1 monocyte to trophoblast adhesion was mediated by the fractalkine/CX3CR1 system, the interaction of fractalkine and its receptor was blocked by addition of human recombinant fractalkine (rhCX3CL1). Pre-incubation of THP-1 monocytes with 5 and 10 ng/ml rhCX3CL1 significantly impaired adherence to Forskolin-stimulated BeWo cells by 41.9 and 37.3 %, respectively (Fig. 3b) . A similar effect was observed in coculture experiments with THP-1 monocytes and primary term trophoblasts. Pre-incubation of THP-1 monocytes with 10 ng/ml rhCX3CL1 markedly reduced adhesion of monocytes by 65.7 % (±0.07), compared with control (Fig. 3c) .
Besides blocking experiments, silencing of CX3CR1 expression in THP-1 monocytes was performed as a second strategy to elucidate the involvement of the fractalkine/CX3CR1 system in monocyte to trophoblast adhesion. qPCR analysis revealed a mean silencing efficiency of CX3CR1 expression by 55.9 % (±14.2) in THP-1 monocytes transfected with siRNA-targeting CX3CR1, compared to non-targeting control (Fig. 4a) 24 h after transfection. Western Blot analysis confirmed qPCR data and showed a significant decrease of CX3CR1 protein to 62.6 % (±0.03) in cells transfected with siCX3CR1, compared with control (Fig. 4b) . Silencing of CX3CR1 expression in THP-1 monocytes significantly reduced their adhesion to Forskolin-stimulated BeWo cells by 46.3 %, compared with control (Fig. 4c) . In contrast, adhesion of CX3CR1-silenced THP-1 monocytes to undifferentiated BeWo cells decreased by only 18.9 % (Fig. 4c) , which did not reach statistical significance and may be explained . Pre-incubation of THP-1 monocytes with 10 ng/ml of rhCX3CL1 significantly decreased adherence to primary term trophoblasts (c). Data are presented as mean ± SEM from four independent BeWo cell experiments and three different term trophoblast isolations all performed in triplicates. *p < 0.05; **p < 0.01; ***p < 0.001 by virtually no fractalkine expression in undifferentiated BeWo cells.
Discussion
Close cellular interaction and a synergistic dialog between fetal and maternal cells is a prerequisite for successful pregnancy. This interaction is not restricted to very early processes of pregnancy, including implantation of the blastocyst or invasion of the extravillous trophoblast population into the maternal decidua, but also takes place later during ongoing gestation. Indeed, dissolution of the endovascular trophoblast plugs within the lumen of invaded spiral arteries at the end of first trimester results in onset of maternal blood flow into the intervillous space, enabling direct contact of circulating maternal blood cells and trophoblastic surfaces, i.e., the syncytiotrophoblast. However, under inflammatory conditions, the interaction and dialog between circulating maternal blood cells, in particular leukocytes, and the syncytiotrophoblast may get unbalanced and lead to damage of the epithelial integrity. Adhesive properties of the syncytiotrophoblast are mediated through expression of molecules such as E-selectin, intercellular adhesion molecule (ICAM)-1 and ICAM-3 (Dye et al. 2001; Labarrere et al. 2014; Xiao et al. 1997 ).
The present study suggests fractalkine as another candidate among the panel of adhesion molecules enabling stable interaction between leukocytes and the syncytiotrophoblast. Our previous and current experiments with BeWo cells and primary term trophoblasts provide strong evidence that fractalkine expression is induced during differentiation and syncytialization from the mononucleated to the multinucleated state of villous trophoblast (Siwetz et al. 2014 ). This assumption is in good agreement with previous immunohistological observations, showing placental fractalkine located at the apical microvillous plasma membrane of the syncytiotrophoblast, but not in villous cytotrophoblasts (Siwetz et al. 2014) . Differentiation of BeWo cells does not seem to be accompanied with induction of CX3CR1 expression, which was neither detected in undifferentiated nor differentiated BeWo cells. This observation is in contrast to a previous study by Hannan et al. (2006) who detected CX3CR1 expression in the trophoblast cell lines JEG-3, AC1M-32 and AC1M-88. Moreover, immunohistochemistry localized weak CX3CR1 expression in extravillous trophoblasts, the syncytiotrophoblast and the cell column of first trimester tissue, suggesting a role of fractalkine and its receptor CX3CR1 in trophoblast differentiation and directed trophoblast invasion. However, with ongoing pregnancy, CX3CR1 expression may be downregulated in the villous trophoblast, as CX3CR1 was only detected in the fetal endothelium but not the villous trophoblast compartment at term (Joerink et al. 2011; Szukiewicz et al. 2013) .
Here, two experimental strategies, including blocking as well as silencing of the fractalkine receptor CX3CR1, proved involvement of the fractalkine/CX3CR1 system in monocyte to villous trophoblast adherence in vitro. Our results also clearly demonstrate that stable monocyte to trophoblast interaction may be driven by more than fractalkine alone. First, monocytes not only adhered to differentiated, but also to undifferentiated BeWo cells, where fractalkine is virtually not expressed. Secondly, blocking and silencing of CX3CR1 in THP-1 monocytes did not completely abolish their adherence to differentiated BeWo and primary term trophoblasts, suggesting involvement of additional adherence mediators in our cell co-culture models. One putative candidate molecule may be ICAM-1, which was previously demonstrated to mediate monocyte adhesion to BeWo cells and primary trophoblasts in response to pro-inflammatory cytokines (Pfaff et al. 2005; Xiao et al. 1997) . Pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-17A, tumor necrosis factor (TNF)-α and interferon (IFN)-gamma, are described to upregulate fractalkine expression in various epithelial cell types (Bhavsar et al. 2008; Dudas et al. 2011; Turner et al. 2010) . Thus, it is tempting to speculate about upregulation of placental fractalkine under pro-inflammatory conditions and its implications on adhesion of monocytes to the syncytiotrophoblast. Tightly adherent monocytes are suggested to facilitate transmission of cell-associated infectious pathogens across the placental barrier by either mediating direct infection of the trophoblast or transmigration of infected cells into the villous stroma (Labarrere et al. 2014; Xiao et al. 1997) . Transmigration of maternal leukocytes could be enabled by local disruption of the syncytiotrophoblast by adhering monocytes, which release TNF-α and thereby contribute to the initiation of villitis (Garcia-Lloret et al. 2000) . Moreover, upregulation of placental fractalkine, in response to pro-inflammatory cytokines, may also facilitate intervillous monocyte recruitment in cases of massive chronic intervillositis, which is characterized by the presence of a CD45-and CD68-reactive monocyte/macrophage infiltrate located almost exclusively between the villi (Labarrere et al. 2014) .
In contrast, physiological implications of stable adhesion of maternal monocytes to the syncytiotrophoblast in healthy pregnancy are rather speculative. Xiao et al. (1997) suggested that adhesion of monocytes to the syncytiotrophoblast may be a normal mechanism of trophoblast renewal. Interestingly, fractalkine expression as well as trophoblast apoptosis is induced by TNF-α and thus could be coordinated events (Bazan et al. 1997; Yui et al. 1994) . Whether placental fractalkine mediates detection and elimination of aged trophoblasts by monocytes remains open. Another interesting hypothesis has recently been raised by Grasso et al., suggesting a bidirectional modulation of chemoattractant signals upon monocyte-trophoblast interaction. Accordingly, trophoblasts may be able to attract and prime monocytes to release a particular set of cytokines supporting their growth and survival (Grasso et al. 2014) .
The fact that fractalkine is detected almost all over the microvillous plasma membrane of the syncytiotrophoblast in healthy placenta raises, however, the question by which mechanisms excessive adherence of CX3CR1 expressing maternal monocytes to the syncytiotrophoblast is prevented. One potential explanation may be sequestration of the CX3CR1 receptor on leukocytes by soluble fractalkine, which can be released from not only the maternal endothelium, but also the syncytiotrophoblast (Siwetz et al. 2014) . Another explanation as to how CX3CR1-expressing maternal monocytes are prevented from stable adherence to the syncytiotrophoblast may be detachment of transiently adhering monocytes by metalloprotease-dependent cleavage of transmembrane fractalkine. Metalloprotease-dependent shedding of transmembrane fractalkine has been suggested to generally decrease the adhesiveness of endothelial or epithelial cells for leukocytes, whereas absence of shedding activity mediates enhanced leukocyte adhesion to fractalkine-expressing cells (Hundhausen et al. 2007; Schwarz et al. 2010) . Shedding was also suggested to play an instrumental role after adherence of leukocytes to transmembrane fractalkine, resulting in detachment of adhered cells. Shedding of placental fractalkine from the syncytiotrophoblast microvillous plasma membrane occurs constitutively and may even be enhanced by stimulation. Interestingly, expression of both involved metalloproteases, a disintegrin and metalloprotease (ADAM)10 and ADAM17, has been shown to be increased in placentas from pregnancies complicated by pre-eclampsia (Yang et al. 2012; Zhao et al. 2010) , suggesting a mechanism preventing fractalkine-mediated leukocyte to syncytiotrophoblast adherence in this pregnancy pathology. Concerning the fractalkine/CX3CR1 system in human pregnancy, a well-controlled balance between CX3CR1-expressing maternal leukocytes, placental transmembrane fractalkine and maternal serum level of soluble fractalkine may thus influence the degree of leukocyte to syncytiotrophoblast adhesion.
